BiomeSense is Other Healthcare Technology Systems in United States that focus on improved ability business. Founded in 2018. They cover business area such as developer, analysis, gut microbiome datum, clinical research, stool sample, user intervention, dense time-series datum generation, doctor, end, more datum, improved ability, novel microbiome-base biomarker, therapeutic.
Other Healthcare Technology Systems
2018
( 8 years old in 2026 )
Improved Ability
-
1452 East 53rd Street
2nd Floor
Chicago, IL 60615
United States
Private
developeranalysisgut microbiome datumclinical researchstool sampleuser interventiondense time-series datum generationdoctorendmore datumimproved abilitynovel microbiome-base biomarkertherapeutic
* We use standard office opening hours in near BiomeSense's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
BiomeSense is Other Healthcare Technology Systems business from United States that founded in 2018 (8 years old in 2026), BiomeSense business is focusing on Improved Ability.
BiomeSense headquarter office and corporate office address is located in 1452 East 53rd Street 2nd Floor Chicago, IL 60615 United States.
BiomeSense was founded in United States.
In 2026, BiomeSense is currently focus on improved ability sector.
Above is snippet of Google Trends for "improved ability" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with BiomeSense, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.